VCU Massey Cancer Center

Menu

VCU Massey Cancer Center Cancer Care Symposium

Saturday, October 5, 2019
7:30 am – 1:15 pm

VCU McGlothlin Medical Education Center
3rd Floor Auditorium
1201 E Marshall St.
Richmond, VA 23298

Please join us for an educational and engaging day of presentations and discussions focused on the latest in lung and breast cancer care and CAR T-cell therapies.

Target Audience

Our target audience for this medical symposium is primary care health providers, specialists, hospital medical and nursing staff, pharmacists and other medical professionals.

Accreditation and Educational Credits

Continuing medical education credit pending.

Registration

This is a FREE educational conference. Online registration is required and space is limited, so please register early.

Online registration will open soon at cme.vcuhealth.org

Registration deadline: September 29, 2019

For more information

Call CJ James, event coordinator at VCU Massey Cancer Center, at (804) 828-3998.

Agenda

7:30 am: Breakfast and Pharmaceutical Exhibit

7:50 am: Welcome Remarks and Introduction

Steven Grossman, M.D., Ph.D., deputy director, Dianne Nunnally Hoppes Endowed Chair in Cancer Research and member of the Cancer Molecular Genetics and Developmental Therapeutics research programs at VCU Massey Cancer Center; professor and chair of the Division of Hematology, Oncology and Palliative Care at the VCU School of Medicine

8 am: Updates in CAR-T and Cellular Therapies at VCU

John McCarty, M.D., director of Cellular Immunotherapies and Transplant and member of the Developmental Therapeutics research program at VCU Massey Cancer Center; professor in the Division of Hematology, Oncology and Palliative Care at the VCU School of Medicine

Learning objectives: Understand the biologic basis for cellular immunotherapy in cancer therapy; become aware of current and impending clinical indications for these therapies; and be informed of upcoming trials and potential expansion of these indications. 

8:30 am: Neoadjuvant Treatment and Immunotherapy for Breast Cancer

Harry Bear, M.D., Ph.D., Walter Lawrence, Jr. Distinguished Professor in Oncology, chair of the Protocol Review & Monitoring Committee and member of the Developmental Therapeutics research program at VCU Massey Cancer Center; professor and chair of the Division of Surgical Oncology and professor of microbiology and immunology at the VCU School of Medicine

Learning objectives: Know how primary systemic (neoadjuvant) therapy has changed the management of breast cancer; understand how immune response indicators impact prognosis and predict responses in breast cancer; and learn about the clinical impact of immune therapy for breast cancer.

9 am: Accelerated Radiation Treatment for Early Stage Breast Cancer

Douglas Arthur, M.D., Florence and Hyman Meyers Endowed Chair in Radiation Oncology, associate director for clinical affairs and member of the Developmental Therapeutics research program at VCU Massey Cancer Center; professor and chair of the Department of Radiation Oncology at the VCU School of Medicine

Learning objective: Review and appreciate published accelerated treatment approaches for early stage breast cancer.

9:30 am: Neoadjuvant Therapy of HER2+ and Triple-Negative Breast cancer – An Evolving Standard of Care

Charles Geyer, Jr., M.D., Harrigan, Haw, Luck Families Chair in Cancer Research, associate director for clinical research and member of the Developmental Therapeutics research program at VCU Massey Cancer Center; professor in the Division of Hematology, Oncology and Palliative Care at the VCU School of Medicine

Learning objective: Understand recent practice-changing clinical trial data, which have made neoadjuvant therapy a standard of care in early breast cancer.

10 am: Coffee Break and Pharmaceutical Exhibit

10:15 am: Lung Cancer Screening Update: Early Detection with Low-Dose CT (LDCT)

Mark Parker, M.D., radiologist, director of the Lung Cancer Screening Program, co-section chief of Cardiothoracic Imaging
 and director of the Thoracic Imaging Fellowship at VCU Health; professor in the Department of Radiology at the VCU School of Medicine

Learning objectives: Review the epidemiology of lung cancer and the evolution of lung cancer screening; address how we currently screen for lung cancer; and understand the application of the LungRADS reporting system.

10:45 am: Biomarkers for Lung Cancer Early Detection

Patrick Nana-Sinkam, M.D., pulmonologist, Linda Grandis Blatt Endowed Chair in Cancer Research and member of the Cancer Cell Signaling and Cancer Prevention and Control research programs at VCU Massey Cancer Center; professor and chair of the Division of Pulmonary Disease and Critical Care Medicine at the VCU School of Medicine

Learning objectives: Review principles for biomarker development and application; review models for lung cancer risk stratification; and discuss implementation of biomarkers in clinical decision making.

11:15 am: Lung Cancer Diagnosis and Surgical Treatment

Anthony Cassano, M.D., cardiothoracic surgeon and member of the Developmental Therapeutics research program at VCU Massey Cancer Center; director of the Thoracic Surgical Department at VCU Health System; professor and chair of the Division of Cardiothoracic Surgery at the VCU School of Medicine

Learning objectives: Discuss how to diagnosis lung cancer, identify the surgical indications for lung cancer and consider alternatives to surgery.

11:45 am: New Advancements in Lung Cancer Treatment

Tzann Fang, M.D., medical oncologist and hematologist at VCU Massey Cancer Center; associate clinical professor in the Division of Hematology, Oncology and Palliative Care at the VCU School of Medicine

Learning objectives: Discuss new diagnostic tests, which can differentiate the subsets of lung cancer, with prognostic or predictive value; and review updates on novel treatments, such as target therapies or immune-modulated therapies.

12:15 pm: Lunch